Iitaka, Sayuri
Kuroda, Akihiro
Narita, Tomonori
Hatakeyama, Hideyuki
Morishita, Masayo
Ungkulpasvich, Umbhorn
Hirotsu, Takaaki
di Luccio, Eric
Yagi, Koichi
Seto, Yasuyuki
Article History
Received: 20 July 2024
Accepted: 11 December 2024
First Online: 18 December 2024
Change Date: 9 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12885-025-13451-2
Declarations
:
: All procedures followed in this study were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the World Medical Association Declaration of Helsinki. The institutional Ethical Review Board of the University of Tokyo Hospital approved this study (2020122NI). This study was registered with UMIN (UMIN000042740).Informed consent statement: We obtained written informed consent from all patients prior to all study-related procedures in this study.
: Not applicable.
: T.H. is the CEO and founder of Hirotsu Bio Science Inc.; E.d.L., H.H., M.M., and U.U. are Hirotsu Bio Science Inc. employees.